Loading...
A new histone deacetylase inhibitor improves liverfibrosis in BDL rats through suppression of hepatic stellate cells
BACKGROUND AND PURPOSE: Activation of hepatic stellate cells (HSCs) is a crucial step in the pathogenesis of hepatic fibrosis. Histone deacetylase (HDAC) is an attractive target in liver fibrosis because it plays a key role in gene expression and cell differentiation. We have developed a HDAC inhibi...
Na minha lista:
| Udgivet i: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BlackWell Publishing Ltd
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4232907/ https://ncbi.nlm.nih.gov/pubmed/24467283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12590 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|